CVRX
HEALTHCARECVRx Inc
AI Insight
What's Moving CVRX Today?
No stock-specific AI insight has been generated for CVRX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$4.37$11.30
$5.15
Fundamentals
Market Cap$131M
P/E Ratio—
EPS$-2.02
Dividend Yield—
Dividend / Share—
ROE-107.0%
Profit Margin-89.1%
Debt / Equity—
Trading
Volume311K
Avg Volume (10D)—
Shares Outstanding26.5M
CVRX News
28 articles- CVRx Announces Chief Financial Officer TransitionYahoo Finance·Jun 9, 2026
- [Form 3] CVRx, Inc. Initial Statement of Beneficial OwnershipStock Titan·Jun 3, 2026
- [Form 4] CVRx, Inc. Insider Trading ActivityStock Titan·Jun 3, 2026
- Martha Shadan of CVRx, Inc. (CVRX) receives stock and option grantsStock Titan·Jun 3, 2026
- CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare ConferenceYahoo Finance·May 27, 2026
- CVRx to Present at the William Blair 46th Annual Growth Stock ConferenceYahoo Finance·May 20, 2026
- CVRx marks 25th Barostim implant milestone at UNC Medical Center Chapel HillTraders Union·May 19, 2026
- CVRx Stock Up on Humana's Medicare Coverage for Barostim TherapyYahoo Finance·May 18, 2026
- CVRx Inc stock (US12674F1003): Medtronic takeover bid puts heart-device specialist in the spotlightAD HOC NEWS·May 18, 2026
- Analysts Have Made A Financial Statement On CVRx, Inc.'s (NASDAQ:CVRX) First-Quarter ReportYahoo Finance·May 15, 2026
- CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim TherapyYahoo Finance·May 14, 2026
- Down 31.7% in 4 Weeks, Here's Why You Should You Buy the Dip in CVRx (CVRX)Yahoo Finance·May 13, 2026
- CVRx (CVRX) Q1 Loss Of US$13.1 Million Tests Bullish Revenue Growth NarrativeSimply Wall Street·May 13, 2026
- CVRx, Inc. (NASDAQ:CVRX) Q1 2026 Earnings Call TranscriptInsider Monkey·May 12, 2026
- CVRx Inc (CVRX) Q1 2026 Earnings Call Highlights: Strong U.S. Growth and Market Expansion PotentialYahoo Finance·May 12, 2026
- CVRx Q1 Earnings Call HighlightsMarketbeat·May 11, 2026
- CVRx (CVRX) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 11, 2026
- CVRx Reports First Quarter 2026 Financial and Operating ResultsYahoo Finance·May 11, 2026
- Pacific Biosciences of California (PACB) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 7, 2026
- CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded PopulationYahoo Finance·May 4, 2026
- CVRx (CVRX) Could Find a Support Soon, Here's Why You Should Buy the Stock NowYahoo Finance·May 1, 2026
- CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026Yahoo Finance·Apr 27, 2026
- CVRx Announces Nomination of Michael Dale for Election to the Board of DirectorsYahoo Finance·Apr 20, 2026
- CVRx Reports Preliminary First Quarter 2026 Financial ResultsYahoo Finance·Apr 13, 2026
- CVRx, Inc. Investigated by the Portnoy Law FirmGlobeNewswire Inc.·Apr 9, 2026
- CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual MeetingYahoo Finance·Mar 2, 2026
- CVRx Inc (CVRX) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions Amid ...Yahoo Finance·Feb 16, 2026
- Analysts Are Updating Their CVRx, Inc. (NASDAQ:CVRX) Estimates After Its Full-Year ResultsYahoo Finance·Feb 15, 2026
All 28 articles loaded
Price Data
Open$4.81
Previous Close$4.86
Day High$5.30
Day Low$4.81
52 Week High$11.30
52 Week Low$4.37
52-Week Range
$4.37$11.30
$5.15
Fundamentals
Market Cap$131M
P/E Ratio—
EPS$-2.02
Dividend Yield—
Dividend / Share—
ROE-107.0%
Profit Margin-89.1%
Debt / Equity—
Trading
Volume311K
Avg Volume (10D)—
Shares Outstanding26.5M
About CVRx Inc
CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—